Novartis Investigative Site
Cegléd 2700
0 studies enrolling now · 4 studies all time
What they study most
Acute Heart Failure, Asthma, Cardiovascular Disease and Lipoprotein(a), Heart Failure With Preserved Ejection Fraction
Studies at this site
- Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
- Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
- A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma — Completed
- Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed